$WSTRF
Western Uranium & Vanadium Corp.

2024 Q4 Form 10-Q Financial Statement

#000121390024097878 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $52.98K
YoY Change -40.57%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.355M
YoY Change 98.09%
Operating Profit -$2.302M
YoY Change 109.33%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$2.241M
YoY Change 111.42%
Net Earnings / Revenue -4230.14%
Basic Earnings Per Share -$0.04
Diluted Earnings Per Share -$0.04
COMMON SHARES
Basic Shares Outstanding 55.22M shares 55.22M shares
Diluted Shares Outstanding 55.22M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $6.646M
Short-Term Investments
Other Short-Term Assets $86.18K
YoY Change -25.24%
Inventory
Prepaid Expenses $205.6K
Receivables
Other Receivables
Total Short-Term Assets $7.013M
YoY Change 13.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $25.90M
YoY Change 4.95%
TOTAL ASSETS
Total Short-Term Assets $7.013M
Total Long-Term Assets $25.90M
Total Assets $32.91M
YoY Change 6.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $263.7K
YoY Change 53.32%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $838.5K
YoY Change 28.41%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $838.5K
Total Long-Term Liabilities
Total Liabilities $4.157M
YoY Change 6.0%
SHAREHOLDERS EQUITY
Retained Earnings -$26.16M
YoY Change 52.85%
Common Stock $55.18M
YoY Change 24.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.75M
YoY Change
Total Liabilities & Shareholders Equity $32.91M
YoY Change 6.65%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$2.241M
YoY Change 111.42%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
us-gaap Interest Paid Net
InterestPaidNet
usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1271843
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M5H 2S8
dei Security12b Title
Security12bTitle
N/A
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2023Q3 us-gaap Other Income
OtherIncome
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55626
dei Entity Registrant Name
EntityRegistrantName
WESTERN URANIUM & VANADIUM CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A6
dei Entity Address Address Line1
EntityAddressAddressLine1
330 Bay Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1400
dei Entity Address City Or Town
EntityAddressCityOrTown
Toronto
dei Entity Address Country
EntityAddressCountry
CA
dei City Area Code
CityAreaCode
(970)
dei Local Phone Number
LocalPhoneNumber
864-2125
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55223113 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6646402 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9217585 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
75075 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
75075 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
205644 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
382314 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
385 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
86183 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
131255 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
7013304 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
9806614 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
737918 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
676369 usd
CY2024Q3 wstrf Property Plant Equipment And Mineral Properties Net
PropertyPlantEquipmentAndMineralPropertiesNet
15670078 usd
CY2023Q4 wstrf Property Plant Equipment And Mineral Properties Net
PropertyPlantEquipmentAndMineralPropertiesNet
14926289 usd
CY2024Q3 wstrf Ablation Intellectual Property
AblationIntellectualProperty
9488051 usd
CY2023Q4 wstrf Ablation Intellectual Property
AblationIntellectualProperty
9488051 usd
CY2024Q3 us-gaap Assets
Assets
32909351 usd
CY2023Q4 us-gaap Assets
Assets
34897323 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
763442 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
761123 usd
CY2024Q3 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
75057 usd
CY2023Q4 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
75057 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
838499 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
836180 usd
CY2024Q3 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
262880 usd
CY2023Q4 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
241562 usd
CY2024Q3 wstrf Deferred Tax Liability
DeferredTaxLiability
2708887 usd
CY2023Q4 wstrf Deferred Tax Liability
DeferredTaxLiability
2708887 usd
CY2024Q3 wstrf Deferred Contingent Considerations
DeferredContingentConsiderations
346820 usd
CY2023Q4 wstrf Deferred Contingent Considerations
DeferredContingentConsiderations
340650 usd
CY2024Q3 us-gaap Liabilities
Liabilities
4157086 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4127279 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55223419 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50002395 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55223113 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50002089 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
55178572 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
49661910 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
306 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
306 shares
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26161437 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18817857 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-264870 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74009 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
28752265 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
30770044 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32909351 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
34897323 usd
CY2024Q3 us-gaap Revenues
Revenues
52981 usd
CY2023Q3 us-gaap Revenues
Revenues
89144 usd
us-gaap Revenues
Revenues
147035 usd
us-gaap Revenues
Revenues
357908 usd
CY2024Q3 wstrf Mining Expenditure
MiningExpenditure
1166343 usd
CY2023Q3 wstrf Mining Expenditure
MiningExpenditure
730854 usd
wstrf Mining Expenditure
MiningExpenditure
3860173 usd
wstrf Mining Expenditure
MiningExpenditure
1992503 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
127049 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
44382 usd
us-gaap Professional Fees
ProfessionalFees
484926 usd
us-gaap Professional Fees
ProfessionalFees
303312 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
813403 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
365197 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2604516 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1384316 usd
CY2024Q3 wstrf Consulting Fees
ConsultingFees
247850 usd
CY2023Q3 wstrf Consulting Fees
ConsultingFees
48251 usd
wstrf Consulting Fees
ConsultingFees
738204 usd
wstrf Consulting Fees
ConsultingFees
48988 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
2354645 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1188684 usd
us-gaap Operating Expenses
OperatingExpenses
7687819 usd
us-gaap Operating Expenses
OperatingExpenses
3729119 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2301664 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1099540 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-7540784 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3371211 usd
CY2024Q3 wstrf Accretion And Interestincome Expense Net
AccretionAndInterestincomeExpenseNet
62492 usd
CY2023Q3 wstrf Accretion And Interestincome Expense Net
AccretionAndInterestincomeExpenseNet
39498 usd
wstrf Accretion And Interestincome Expense Net
AccretionAndInterestincomeExpenseNet
199202 usd
wstrf Accretion And Interestincome Expense Net
AccretionAndInterestincomeExpenseNet
126979 usd
CY2024Q3 us-gaap Other Income
OtherIncome
-1998 usd
us-gaap Other Income
OtherIncome
-1998 usd
us-gaap Other Income
OtherIncome
4000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2241170 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1060042 usd
us-gaap Net Income Loss
NetIncomeLoss
-7343580 usd
us-gaap Net Income Loss
NetIncomeLoss
-3240232 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14018 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-43474 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-190861 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
14716 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2227152 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1103516 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7534441 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3225516 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55223113 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55223113 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43609774 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43609774 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54338493 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54338493 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43604977 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43604977 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
30770044 usd
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-142359 usd
CY2024Q1 wstrf Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
4605458 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
522862 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2476888 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
33279117 usd
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-62520 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
236442 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-2625522 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
30827517 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
14018 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
151900 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2241170 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
28752265 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
29257908 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
6314 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
252742 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1103531 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
28413433 usd
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
51876 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
98158 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1076659 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
27486808 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-43474 usd
CY2023Q3 wstrf Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
551629 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1060042 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
26934921 usd
us-gaap Net Income Loss
NetIncomeLoss
-7343580 usd
us-gaap Net Income Loss
NetIncomeLoss
-3240232 usd
us-gaap Depreciation
Depreciation
433148 usd
us-gaap Depreciation
Depreciation
163223 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1998 usd
wstrf Accretion Of Reclamation Liability
AccretionOfReclamationLiability
9164 usd
wstrf Accretion Of Reclamation Liability
AccretionOfReclamationLiability
9321 usd
us-gaap Share Based Compensation
ShareBasedCompensation
893688 usd
us-gaap Share Based Compensation
ShareBasedCompensation
350900 usd
wstrf Change In Marketable Securities
ChangeInMarketableSecurities
385 usd
wstrf Change In Marketable Securities
ChangeInMarketableSecurities
189 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-221742 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-185657 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2319 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
26333 usd
wstrf Increase Decrease In Reclamation Liability
IncreaseDecreaseInReclamationLiability
12154 usd
wstrf Increase Decrease In Reclamation Liability
IncreaseDecreaseInReclamationLiability
4035 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-43860 usd
wstrf Increase Decrease In Contingent Consideration
IncreaseDecreaseInContingentConsideration
-6170 usd
wstrf Increase Decrease In Contingent Consideration
IncreaseDecreaseInContingentConsideration
18853 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5762812 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2563287 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
1182935 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
1874183 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1178935 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1874183 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4605458 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
551629 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4605458 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
551629 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-173345 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14716 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2509634 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3871125 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9969029 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10433538 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7459395 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6562413 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6646402 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5810969 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
75075 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
75075 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
737918 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
676369 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7459395 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6562413 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2241170 usd
us-gaap Net Income Loss
NetIncomeLoss
-7343580 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26161437 usd
CY2024Q3 wstrf Working Capitals
WorkingCapitals
6174805 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
4605458 usd
CY2023Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
5215828 shares
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.02
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.39
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5324988 usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
7250000 cad
CY2023 wstrf Proceeds From Issuance Of Net Proceeds
ProceedsFromIssuanceOfNetProceeds
4836867 usd
CY2023 wstrf Proceeds From Issuance Of Net Proceeds
ProceedsFromIssuanceOfNetProceeds
6588089 cad
CY2024Q3 us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
false
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of these condensed interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and revenues and expenses during the periods reported. By their nature, these estimates are subject to measurement uncertainty, and the effects on the condensed interim consolidated financial statements of changes in such estimates in future periods could be significant. Significant areas requiring management’s estimates and assumptions include the determination of the fair value of transactions involving common shares, assessment of the useful life and evaluation for impairment of Kinetic Separation intellectual property, valuation and impairment assessments of mineral properties and equipment, valuation of deferred contingent consideration, valuation of the reclamation liability and valuation of stock-based compensation. Other areas requiring estimates include allocations of expenditures, depletion, and amortization of mineral rights and properties. Actual results could differ from those estimates.</p>
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10052073 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12476410 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10052073 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12476410 shares
CY2024Q3 wstrf Property Plant And Equipment And Mineral Properties Gross
PropertyPlantAndEquipmentAndMineralPropertiesGross
16420220 usd
CY2023Q4 wstrf Property Plant And Equipment And Mineral Properties Gross
PropertyPlantAndEquipmentAndMineralPropertiesGross
15247940 usd
CY2024Q3 wstrf Accumulated Depreciation Property Plant And Equipment And Mineral Properties
AccumulatedDepreciationPropertyPlantAndEquipmentAndMineralProperties
750142 usd
CY2023Q4 wstrf Accumulated Depreciation Property Plant And Equipment And Mineral Properties
AccumulatedDepreciationPropertyPlantAndEquipmentAndMineralProperties
321651 usd
CY2024Q3 wstrf Property Plant And Equipment And Mineral Properties Net
PropertyPlantAndEquipmentAndMineralPropertiesNet
15670078 usd
CY2023Q4 wstrf Property Plant And Equipment And Mineral Properties Net
PropertyPlantAndEquipmentAndMineralPropertiesNet
14926289 usd
CY2024Q3 wstrf Ablation Intellectual Property
AblationIntellectualProperty
9488051 usd
CY2023Q4 wstrf Ablation Intellectual Property
AblationIntellectualProperty
9488051 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
1182935 usd
us-gaap Payments To Acquire Mining Assets
PaymentsToAcquireMiningAssets
1874183 usd
CY2024Q3 us-gaap Area Of Land
AreaOfLand
160 acre
CY2024Q3 us-gaap Payments To Acquire Royalty Interests In Mining Properties
PaymentsToAcquireRoyaltyInterestsInMiningProperties
52981 usd
CY2023Q3 us-gaap Payments To Acquire Royalty Interests In Mining Properties
PaymentsToAcquireRoyaltyInterestsInMiningProperties
89144 usd
us-gaap Payments To Acquire Royalty Interests In Mining Properties
PaymentsToAcquireRoyaltyInterestsInMiningProperties
147035 usd
us-gaap Payments To Acquire Royalty Interests In Mining Properties
PaymentsToAcquireRoyaltyInterestsInMiningProperties
357908 usd
wstrf Increase Decrease In Reclamation Liability Gross
IncreaseDecreaseInReclamationLiabilityGross
61403 usd
wstrf Increase Decrease In Reclamation Liability
IncreaseDecreaseInReclamationLiability
12154 usd
CY2024Q3 us-gaap Asset Retirement Obligation
AssetRetirementObligation
812027 usd
CY2023Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
751444 usd
CY2024Q3 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
75057 usd
wstrf Reclamation Liability Discount Rate
ReclamationLiabilityDiscountRate
0.054 pure
CY2024Q3 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
262880 usd
CY2023Q4 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
241562 usd
CY2024Q3 wstrf Gross Reclamation Liabilities
GrossReclamationLiabilities
812027 usd
CY2023Q4 wstrf Gross Reclamation Liabilities
GrossReclamationLiabilities
751444 usd
CY2023Q4 wstrf Accrued Reclamation Costs
AccruedReclamationCosts
316619 usd
CY2022Q4 wstrf Accrued Reclamation Costs
AccruedReclamationCosts
300276 usd
wstrf Increase Decrease In Reclamation Liability
IncreaseDecreaseInReclamationLiability
12154 usd
wstrf Increase Decrease In Reclamation Liability
IncreaseDecreaseInReclamationLiability
4035 usd
wstrf Accretion Of Reclamation Liability
AccretionOfReclamationLiability
9164 usd
wstrf Accretion Of Reclamation Liability
AccretionOfReclamationLiability
9321 usd
CY2024Q3 wstrf Accrued Reclamation Costs
AccruedReclamationCosts
337937 usd
CY2023Q3 wstrf Accrued Reclamation Costs
AccruedReclamationCosts
313632 usd
CY2024Q3 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
75057 usd
CY2023Q3 us-gaap Accrued Reclamation Costs Current
AccruedReclamationCostsCurrent
75057 usd
CY2024Q3 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
262880 usd
CY2023Q3 us-gaap Mine Reclamation And Closing Liability Noncurrent
MineReclamationAndClosingLiabilityNoncurrent
238575 usd
CY2024Q3 us-gaap Oil And Gas Reclamation Liability Noncurrent
OilAndGasReclamationLiabilityNoncurrent
60300 usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
499710 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
562831 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
263732 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
198292 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
763442 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
761123 usd
us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of the Company’s common shares are entitled to one vote per share.
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
656000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55223113 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4473334 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.8
CY2024Q3 us-gaap Share Price
SharePrice
2
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0422 pure
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
893688 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y4M2D
CY2024Q3 wstrf Mining Costs
MiningCosts
614454 usd
CY2023Q3 wstrf Mining Costs
MiningCosts
421064 usd
wstrf Mining Costs
MiningCosts
1967452 usd
wstrf Mining Costs
MiningCosts
1042186 usd
CY2024Q3 wstrf Payments To Acquire Mining Permits
PaymentsToAcquireMiningPermits
28267 usd
CY2023Q3 wstrf Payments To Acquire Mining Permits
PaymentsToAcquireMiningPermits
26662 usd
wstrf Payments To Acquire Mining Permits
PaymentsToAcquireMiningPermits
91904 usd
wstrf Payments To Acquire Mining Permits
PaymentsToAcquireMiningPermits
81340 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
523622 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
280704 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1795517 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
863958 usd
CY2023Q3 wstrf Royalties
Royalties
2424 usd
wstrf Royalties
Royalties
5300 usd
wstrf Royalties
Royalties
5019 usd
CY2024Q3 wstrf Mining Expenditure
MiningExpenditure
1166343 usd
CY2023Q3 wstrf Mining Expenditure
MiningExpenditure
730854 usd
wstrf Mining Expenditure
MiningExpenditure
3860173 usd
wstrf Mining Expenditure
MiningExpenditure
1992503 usd
CY2024Q1 wstrf Joint Venture Owns Percentage
JointVentureOwnsPercentage
0.50 pure
CY2024Q3 wstrf Deferred Contingent Considerations
DeferredContingentConsiderations
346820 usd
CY2023Q4 wstrf Deferred Contingent Considerations
DeferredContingentConsiderations
340650 usd
CY2024Q4 us-gaap Area Of Land
AreaOfLand
900 acre
CY2024Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
4166666 shares
CY2024Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
1.32
CY2024Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
5500000 usd
CY2024Q4 wstrf Overallotment Discretionary Percentage
OverallotmentDiscretionaryPercentage
0.15 pure
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
usd
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2024Q3 wstrf Royalties
Royalties
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001621906
dei No Trading Symbol Flag
NoTradingSymbolFlag
true

Files In Submission

Name View Source Status
0001213900-24-097878-index-headers.html Edgar Link pending
0001213900-24-097878-index.html Edgar Link pending
0001213900-24-097878.txt Edgar Link pending
0001213900-24-097878-xbrl.zip Edgar Link pending
ea0220588-10q_western.htm Edgar Link pending
ea022058801ex31-1_western.htm Edgar Link pending
ea022058801ex31-2_western.htm Edgar Link pending
ea022058801ex32-1_western.htm Edgar Link pending
ea022058801ex95_western.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ea0220588-10q_western_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wstrf-20240930.xsd Edgar Link pending
wstrf-20240930_cal.xml Edgar Link unprocessable
wstrf-20240930_def.xml Edgar Link unprocessable
wstrf-20240930_lab.xml Edgar Link unprocessable
wstrf-20240930_pre.xml Edgar Link unprocessable